Pneumococcal macrolide resistance--myth or reality? (Q33718858)

28 July 2017

1 reference

title

Pneumococcal macrolide resistance--myth or reality? (English)

1 reference

28 July 2017

Amsden GW

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

Journal of Antimicrobial Chemotherapy

28 July 2017

published in

1 reference

28 July 2017

volume

44

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-6

1 reference

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Resistance patterns of Streptococcus pneumoniae and Haemophilus influenzae isolates recovered in Egypt from children with pneumonia. The Antimicrobial Resistance Surveillance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Erythromycin, clarithromycin, and azithromycin: are the differences real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Antibiotic Prescribing for Adults With Colds, Upper Respiratory Tract Infections, and Bronchitis by Ambulatory Care Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Pharmacokinetics of Oral Azithromycin in Serum, Urine, Polymorphonuclear Leucocytes and Inflammatory vs Non-Inflammatory Skin Blisters in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

21 January 2018

Identifiers

DOI

10.1093/JAC/44.1.1

1 reference

28 July 2017

1 reference